Curt D. Furberg, MD, an internationally recognized cardiovascular epidemiologist with expertise in clinical trials, drug safety and public health. Dr. Furberg is a Professor Emeritus of Public Health Sciences at Wake Forest University who has chaired NIH’s Antihypertensive and Lipid-Lowering Treatment to . . . Continue reading →
FDA, a complicit partner in crimes and corrupt industry practices have resulted in an epidemic of preventable injuries and deaths. Continue reading →
Part II. What Do We Get for All That Money? A preventable epidemic of injury and death from prescription drugs; FDA’s contribution to the epidemic; Big Pharma’s business model: manufactured myths, propaganda and a hidden agenda;
Since 1995 FDA scientists have been at odds against FDA managers who routinely override sientists’ safety concerns to approve dubious prescription drugs.
Since 1995 FDA scientists have been at odds against FDA managers who routinely override sientists’ safety concerns to approve dubious prescription drugs. Continue reading →
“I’m an investor in Matrixx; I worry whether my stock price is going to go down,” he said. “You can have some psychic come out and say Zicam is going to cause a disease, with no support whatsoever, but if it causes the stock to go down 20 percent, it seems to me that’s material.” Supreme Court Justice Roberts Continue reading →
From 1991-2000 qui tam law suits accounted for only 9% of settlements with the government. But from 2001-2010, qui tam settlements comprised 67% of the billions in payouts Continue reading →
"Daily use of SSRIs was also associated with a four per cent reduction in bone mineral density of the hip and 2.4 per cent of the lower spine, the study found." Continue reading →
FDA's slip-shod approval of defective, harmful drugs, accompanied by rubber stampped endorsements by compromised FDA advisory committees may be reaching a boiling point.
Continue reading →
Cong Greenwood’s version Wed, 21 Jul 2004 Congressman James Greenwood called at 4:05 to inform AHRP of the following: He has resigned from the chairmanship of the House subcommittee on oversight and investigations today. He was offered the job with Biotechnology Industry . . . Continue reading →
Cong Hinchey PRESS CONFERENCE Re: Drug Co. Influence on FDA Sat, 10 Jul 2004 New York Congressman Maurice Hinchey (House Appropriations Committee) is holding a press conference on Tuesday, July 13, 2004, at 10:30 AM to address issues of concern about undue . . . Continue reading →
Forbes: Face of The Year: David Graham Mon, 13 Dec 2004 Forbes magazine has named Dr. David Graham the Face of the Year’ for his “steadfast advocacy of drug safety and his willingness to blow the whistle on his bosses.” Dr. . . . Continue reading →
